Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
John Wiley & Sons A | WLY | Jan 10, 2025 | 42.10 | -1.61 |
John Wiley & Sons B | WLYB | Jan 10, 2025 | 41.95 | +0.38 |
Johnson & Johnson | JNJ | Jan 10, 2025 | 142.06 | -0.15 |
Johnson Controls International | JCI | Jan 10, 2025 | 78.66 | -1.72 |
Johnson Outdoors A | JOUT | Jan 10, 2025 | 33.22 | -3.32 |
Joint Stock Company Kaspi.kz | KSPI | Jan 10, 2025 | 91.63 | -4.25 |
Jones Lang LaSalle | JLL | Jan 10, 2025 | 238.18 | -3.94 |
Journey Medical | DERM | Jan 10, 2025 | 3.83 | -4.25 |
Jowell Global | JWEL | Jan 10, 2025 | 2.96 | -2.29 |
JOYY ADR | YY | Jan 10, 2025 | 38.58 | +0.08 |
JP Morgan Chase | JPM | Jan 10, 2025 | 239.87 | -1.34 |
JP Morgan Chase & Co EE Pref | JPM-C | Jan 10, 2025 | 25.17 | -0.36 |
JP Morgan Chase & Co GG Pref | JPM-J | Jan 10, 2025 | 20.71 | -2.13 |
JP Morgan Chase & Co Ser DD Pref | JPM-D | Jan 10, 2025 | 24.74 | -1.08 |
JPMorgan Nasdaq Equity Premium Income ETF | JEPQ | Jan 10, 2025 | 55.98 | -1.48 |
Jumia Technologies ADR | JMIA | Jan 10, 2025 | 3.83 | -1.03 |
Junee Limited - Ordinary Shares | JUNE | Jan 10, 2025 | 3.42 | -1.72 |
Junior Gold Miners ETF Market Vectors | GDXJ | Jan 10, 2025 | 45.32 | -0.07 |
Juniper Networks | JNPR | Jan 10, 2025 | 38.45 | +0.21 |
Jupiter Neurosciences | JUNS | Jan 10, 2025 | 8.55 | 0.00 |
JVSPAC Acquisition | JVSAU | Jan 10, 2025 | 10.66 | 0.00 |
JVSPAC Acquisition | JVSA | Jan 10, 2025 | 10.49 | +0.10 |
JX Luxventure | JXG | Jan 10, 2025 | 3.38 | 0.00 |
JX Luxventure | JXJT | Jan 10, 2025 | 0.81 | 0.00 |
Kadant | KAI | Jan 10, 2025 | 340.97 | -1.21 |
Kairos Pharma | KAPA | Jan 10, 2025 | 0.97 | -5.83 |
Kairous Acquisition | KACL | Jan 10, 2025 | 12.33 | 0.00 |
Kaiser Aluminium | KALU | Jan 10, 2025 | 70.21 | -0.24 |
Kaival Brands Innovations Group | KAVL | Jan 10, 2025 | 1.12 | +12.00 |
Kaixin Holdings | KXIN | Jan 10, 2025 | 1.56 | +0.65 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.